In African health news this week, the continent reported progress against major diseases even as funding gaps continue to weigh on public-health programs. South Africa has begun trials for its first locally developed cholera vaccine, a move…
LONG viewed with suspicion by cardiologists, coffee may not be the heart rhythm risk many feared. A new multicentre clinical trial suggests that drinking caffeinated coffee could reduce the likelihood of recurrent atrial fibrillation (AF)…
An experimental drug compound could prevent and treat some complications of diabetes, such as poor wound healing and rampant inflammation. And it works regardless of blood sugar control, a new study in mice and human cells suggests.
The…
Researchers on Wednesday reported two promising new approaches to counteract malaria’s…
In recent years, the global prevalence and incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) have been on a yearly upward trend, with the prevalence surging to as high as 37.8% post-2016.1 Specifically,…
An experimental compound has been found to limit cell death, reduce inflammation, and lessen organ damage associated with diabetes.
A research team at NYU Langone Health reported that, in mouse studies, a drug candidate successfully prevented two…
An experimental compound has been found to limit cell death, reduce inflammation, and lessen organ damage associated with diabetes.
A research team at NYU Langone Health reported that, in mouse studies, a drug candidate successfully prevented two…
Gestational diabetes mellitus (GDM) is an increasingly prevalent medical disorder, characterized by impaired glucose tolerance (hyperglycemia) during pregnancy, affecting approximately 14% of all pregnancies worldwide.1–3 GDM has…
